Browse by Poster Presenter

iwCLL X / Twitter

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

U
Uggla, Bertil

1 Section of Hematology, Department of Medicine, Faculty of Medicine and Health, Örebro University
1154 - Impaired long-term antibody persistence after primary immunization with pneumococcal vaccines in patients with chronic lymphocytic leukemia compared to immunocompetent controls
Bertil Uggla
Favorite
Uhlig, Holm

Experimental Medicine Division, Nuffield Department of Medicine, University of Oxford
1202 - T cell type abundance and gene expression patterns in the context of clinical progression of treatment-naïve CLL/MBL patients from the OxPLoreD study
Holm Uhlig
Favorite
Ujjani, Chaitra

Fred Hutchinson Cancer Center / University of Washington School of Medicine
1106 - Clinical Relevance of the Recommended Intensive Laboratory Monitoring during the Standard Ramp-up at Time of Venetoclax Initiation for CLL: A Real-World Experience
Chaitra Ujjani
Favorite
1153 - SWITCHING FROM COVALENT BTKI TO BCL2i IS ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES COMPARED TO SWITCHING TO A DIFFERENT COVALENT BTKI IN PATIENTS WITH CLL/SLL TREATED IN THE REAL-WORLD SETTING
Chaitra Ujjani
Favorite
Uría, Rita

Institut Pasteur de Montevideo
1037 - Activation of S100-A9/EMMPRIN axis triggers survival/proliferation pathways in leukemic cells. A novel target for chronic lymphocytic leukemia
Rita Uría
Favorite
1054 - The RNA-binding protein Musashi2 is regulated by NOTCH1/KLF4 pathway and support tumor survival keeping CLL cells in proliferative niches during disease progression
Rita Uría
Favorite
1144 - Patients with unmutated IgHV_1-69; 1-02; 3-30; 4-39 and high expression of AID enzyme need earlier treatment.
Rita Uría
Favorite
Urban, Aleksandra

Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital
1135 - Predictive modeling of treatment outcomes in chronic lymphocytic leukemia based on functional profiles at baseline
Aleksandra Urban
Favorite
Uribe-Paredes, Roberto

Universidad de Magallanes
1032 - Clonal Space Assessment in Chronic Lymphocytic Leukemia Using an Unbiased NGS Approach
Roberto Uribe-Paredes
Favorite
Uriepero, Angimar

H Lee Moffitt Cancer Center & Research Institute
1026 - Targeting the pro-inflammatory protein S100-A9 in Chronic Lymphocytic Leukemia
Angimar Uriepero
Favorite
1032 - Clonal Space Assessment in Chronic Lymphocytic Leukemia Using an Unbiased NGS Approach
Angimar Uriepero
Favorite
1037 - Activation of S100-A9/EMMPRIN axis triggers survival/proliferation pathways in leukemic cells. A novel target for chronic lymphocytic leukemia
Angimar Uriepero
Favorite
1058 - T-cell Transcriptional and Mitochondrial Fitness Reprogramming in CLL Using PI3Kδ Inhibitors
Angimar Uriepero
Favorite
Utsunomiya, Atae

Imamura General Hospital
1126 - Significance of sIL-2R and LD in predicting time to first treatment in Japanese CLL patients with early asymptomatic disease.
Atae Utsunomiya
Favorite